Search for: "Teva USA" Results 521 - 540 of 714
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Court Report
15 May 2011, 8:55 pm by Patent Docs
• Defendant: Teva Pharmaceuticals USA Inc. [read post]
Patent Docs - http://www.patentdocs.org/
Judge Dalzell: All proceedings before Judge Dalzell STAYED pending confirmation of Richard G. Andrews as U.S. District Judge
13 May 2011, 10:49 am by Pilar G. Kraman
Teva Pharms USA, Inc., C.A. [read post]
Delaware IP Law Blog - http://www.delawareiplaw.com/
Eastman Chemical win on "best mode" affirmed by CAFC
30 Apr 2011, 5:22 am by Lawrence B. Ebert
Teva Pharms. [read post]
IPBiz - http://ipbiz.blogspot.com/
À La Mode
29 Apr 2011, 1:03 pm
Teva Pharms. [read post]
Patent Prospector - http://www.patenthawk.com/blog/
2010 NATIONAL BIGGEST VERDICTS
29 Apr 2011, 7:43 am by PRATER, DUNCAN & CRAIG 770-253-7778
Teva Parenteral Medicines Inc. [read post]
Pratlaw - http://newnaninjuryblog.blogspot.com/
Instant Squealing
24 Apr 2011, 3:45 pm
Claim construction is a legal greased pig: hard to tackle. [read post]
Patent Prospector - http://www.patenthawk.com/blog/
We Dare Defend Established Alabama Law
21 Apr 2011, 1:36 pm by Bexis
Teva Pharmaceuticals USA, Inc., 2007 WL 5787186 (S.D. [read post]
Drug and Device Law - http://druganddevicelaw.blogspot.com/
Lawsuit Alleges False Marking Based on Orange Book “Advertising”
13 Apr 2011, 5:13 pm by FDABlog HPM
  Waiting in the wings for the expiration of Ranbaxy’s 180-day exclusivity is Teva’s tentatively approved ANDA No. 77-344. [read post]
FDA Law Blog - http://www.fdalawblog.net/fda_law_blog_hyman_phelps/
Pharma & Biotech Global Week in Review 6 April 2011 from IP Think Tank
6 Apr 2011, 12:18 am by Marie Louise
Laboratorios Rubió (EPLAW) Gemzar (Gemcitabine) – US: ITC: Target date of 23 July 2012 set in Certain Gemcitabine (ITC 337 Law Blog)  Intuniv (Guanfacine) – US: Shire files patent infringement complaint based on Mylan’s ANDA filing (Patent Docs) Isentress (Raltegravir) – India: Cipla files for compulsory license against Merck’s Isentress (Spicy IP) Losartan, HCTZ – France: Cour d’appel confirms combination products infringe mono-SPCs and sets… [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog
NJ District Court Punts in ASACOL DJ Action to Trigger 180-Day Exclusivity Forfeiture; Rules that Subsequent ANDA Applicant Lacks Standing
5 Apr 2011, 2:35 pm by FDABlog HPM
  Par opposed the Motion to Dismiss arguing that pursuant to the Federal Circuit’s decision in Teva Pharmaceuticals USA, Inc. v. [read post]
FDA Law Blog - http://www.fdalawblog.net/fda_law_blog_hyman_phelps/
Details on today’s orders
28 Mar 2011, 7:32 am by Adam Schlossman
”Certiorari stage documents:Opinion below (3d Circuit)Petition for certiorariBrief in oppositionPetitioners' replyAmicus brief of TEVA Pharmaceuticals USA, Inc.Amicus brief of Consumer Federation of America et al.Amicus brief of Mylan Pharmaceuticals, Inc.Amicus brief of Apotex, Inc.Amicus Generic Pharmaceutical AssociationCVSG Information:Invited: March 28, 2011 The Court rejected all attempts by Georgia death row prisoner Troy Davis to further pursue his claim of… [read post]
SCOTUSblog - http://www.scotusblog.com/
Petitions to watch | Conference of 03.25.11
24 Mar 2011, 12:53 pm by Christa Culver
”Certiorari stage documents:Opinion below (3d Circuit)Petition for certiorariBrief in oppositionPetitioners' replyAmicus brief of TEVA Pharmaceuticals USA, Inc.Amicus brief of Consumer Federation of America et al.Amicus brief of Mylan Pharmaceuticals, Inc.Amicus brief of Apotex, Inc.Amicus Generic Pharmaceutical Association Title: Stovall v. [read post]
SCOTUSblog - http://www.scotusblog.com/
Pharma & Biotech Global Week in Review 23 March 2011 from IP Think Tank
22 Mar 2011, 4:21 pm by Marie Louise
: Board of Trustees of Leland Stanford Junior University v Roche Molecular Systems Inc (IPKat) US: That was unexpectedly…  well… expected: BPAI affirms Examiner’s obviousness rejection in Ex Parte Akio Ochiai concerning a health food product containing curcumin, scymnol and isoflavones (BT-IP Notes) US: VirginiaTech VERSUS series – Drug evaluation DVDs available (FDA Law Blog) Products Diovan HCT (Valsartan, Hydrochlorothiazide) – Germany: Düsseldorf… [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog
Judge Robinson: Teva’s Late Motion for Leave to Amend Pleading DENIED
10 Mar 2011, 3:18 pm by Joseph Gribbin
Teva Pharmaceuticals USA, Inc., Civ. [read post]
Delaware IP Law Blog - http://www.delawareiplaw.com/
District Court’s Extension of 30-Month Stay on Generic XYZAL Approval Ends; ANDA Sponsors are Itching for an FDA Decision on “Carved-Out” Urticaria-Only Labeling
23 Feb 2011, 10:58 am by FDABlog HPM
Teva Pharms. [read post]
FDA Law Blog - http://www.fdalawblog.net/fda_law_blog_hyman_phelps/
No Ill-Plead Evisceration
17 Feb 2011, 6:59 pm
USA, Inc. v. [read post]
Patent Prospector - http://www.patenthawk.com/blog/
N.J. Chief Judge Bartle: Amgen Patents Not Invalid after Bench Trial
28 Jan 2011, 11:38 am by Andrew Russell
Teva Pharmaceuticals USA, Inc., C.A. [read post]
Delaware IP Law Blog - http://www.delawareiplaw.com/
High Court Denies Apotex Petition on 180-Day Exclusivity
18 Jan 2011, 7:42 am by FDABlog HPM
Circuit’s March 2, 2010 decision in Teva Pharms USA, Inc. v. [read post]
FDA Law Blog - http://www.fdalawblog.net/fda_law_blog_hyman_phelps/
Apotex Seeks to Trigger 180-Day Exclusivity for Generic LEXAPRO Tablets
17 Jan 2011, 9:27 am by FDABlog HPM
USA, Inc. v. [read post]
FDA Law Blog - http://www.fdalawblog.net/fda_law_blog_hyman_phelps/
Obviousness Type Double Patenting Does Not Require Later-Issued Patent With Shorter Term to Abridge Term of Earlier-Granted Patent With Longer Term
12 Jan 2011, 6:55 am by The Docket Navigator
Teva Pharmaceuticals USA Inc., et. al., 1-08-cv-00464 (DED January 7, 2011, Order) (Bartle, C.J.) [read post]
Docket Report Patent Infringement Blog - http://docketreport.blogspot.com/